Estrella Immunopharma, Inc.ESLANASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Trend
Above historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
55.97%
↑ 75% above average
Average (4y)
31.95%
Historical baseline
Range
High:203.81%
Low:-100.00%
Volatility
950.7%
High variability
| Period | Value |
|---|---|
| 2024 | 55.97% |
| 2023 | 0.00% |
| 2022 | -100.00% |
| 2021 | 203.81% |
| 2020 | 0.00% |